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Abstract 
As the number of addicted maternal-infant dyads increases, so does the need for 
nursing to expand its understanding of the addiction process and the evidence-
based interventions that best serve mothers and infants. Nursing attitudes toward 
the opioid-addicted mother and infant dyad are influenced by knowledge deficits 
and communication difficulties. Care required encompasses medical, legal, social, 
and economic perspectives. Professionals and society at large have disagreements 
regarding whether to approach the phenomenon from a punitive or supportive strategy. 
Facilities to care for the mother-infant dyad with addiction are limited. Increasing 
knowledge has great potential for active understanding and ability to impact these 
vulnerable patients. Policies must be carefully considered and nuanced. Opportunities 
for research are myriad. Nurses are well positioned to intervene and create positive 
outcomes for mother-infant dyads experiencing opioid addiction.
Introduction 
Drug use in the United States (US), including among pregnant women, is rising: 4.4% 
of pregnant women use illicit drugs, with a much higher rate in women aged 15 to 
25 years. Approximately 180,000 infants annually are born with neonatal abstinence 
syndrome (NAS) (Caitlin, 2012), which can directly affect infant development. Many of 
these infants require prolonged hospitalizations, and multifaceted inter-professional 
skills are required to guide them and their mothers through the period of withdrawal. 
The American Congress of Obstetricians and Gynecologists (ACOG) states that there 
are multifactorial reasons for drug use, which is a biologic and behavioral problem with 
genetic components (ACOG, 2014). Substance abuse affects more people who are 
living in poverty, who have experienced abuse or trauma, and who are unemployed or 
have mental illness. This means that a large percentage of women who deliver opiate-
exposed infants are uninsured or on Medicaid. By one estimate Medicaid will pay one 
trillion dollars for substance abuse over the next twenty years (Coleman & Miller, 2006). 
This translates into problems for families, healthcare systems, legal systems, and 
society. 
22                                                                         Journal of Nursing Doctoral Students Scholarship   •   Vol. 3 / 2015 
Caring for patients with NAS requires empathy, knowledge, and curiosity. It demands 
experience and stamina, which can be corrupted and exhausted. Research indicates 
that nurses feel unprepared to care for these families (Fraser, Barnes, Biggs, & Kain, 
2007; Maguire, Webb, Passmore, & Cline, 2012). Due to increased numbers of opiate-
exposed mother-infant dyads, the stress and challenge of caring for vulnerable families 
is only increasing. The nurse, mother, and infant are in a continual feedback loop 
with the actions of each affecting the reactions of the other (Cleveland & Gill, 2013; 
Cleveland & Bonugli, 2014). Nursing needs to expand its knowledge and understanding 
of the addiction process and the evidence-based interventions that best serve mothers 
and infants.
Background
Hill (2013) defines addiction as a “chronic, relapsing disease that is characterized by 
compulsive drug seeking and use, despite harmful consequences” (p. 183). Addiction 
is a disease of both brain and behavior, and science has yet to understand the various 
reasons why people use drugs or how drugs affect the brain to compel addiction (Hill, 
2013). This lack of understanding creates a chasm into which fall many well-intentioned 
ideas that have no basis in fact.
Nurses may be conflicted by the need to advocate for these vulnerable, sick infants 
whose issues stem directly from maternal actions. They are frequently not trained in 
addiction behaviors and the experiences of those with addiction (Fraser et al., 2007; 
Maguire et al., 2012). This may impede the nurse-mother relationship and in turn 
accentuate negative feelings held by the mother. Hill (2013) notes that lack of a trusting 
relationship can mean a mother is four times less likely to receive adequate preventive 
and ongoing health care. This may include how to bond with her infant. If a nurse can 
impart “competence and confidence” in the mother by focusing on what she can do for 
her infant, she may give the mother the needed boost to care for herself and seek or 
stay in treatment (Hill, 2013).
Without the ability to understand and empathize with the opioid-addicted mother, 
nurses may find themselves frustrated and unintentionally contributing to the failure 
of successful maternal-infant bonding (Fraser et al., 2007). The nurse who lacks an 
understanding of what the mother experiences may reinforce negative behavior such 
as non-visitation on the part of the mother (Cleveland & Gill, 2013; Cleveland & Bonugli, 
2014). Attitudes of the nurse toward the mother, and the ability or inability of the nurse 
to communicate with the mother, impact care of the mother and infant (Cleveland & 
Bonugli, 2014). Additionally, a paucity of maternal education by the nurse on the topic 
of infant cues and signs of withdrawal exhibited by the infant may perpetuate maternal 
actions that exacerbate infant distress (Velez & Jansson, 2008).
Current Trends
There is a growing movement nationally to enact punitive approaches to the opioid-
addicted mother. This may be driven not by evidence but by a perceived need to 
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intervene in the abuse cycle. Nurses are increasingly raising their voices against the 
mother, advocating for foster care (Bauer & Diedrik, 2014) or legal ramifications for the 
mother (B. Hall-Long, personal communication, July 21, 2014). These ideas seem born 
of frustration rather than evidence. Evidence suggests that mothers and infants kept 
together have improved outcomes (Isemann, Meinzen-Derr, & Akinbi, 2011; Saiki, Lee, 
Hannam, & Greenough, 2010). Studies have also pointed out that mandatory reporting 
systems create fear of incarceration and fear of removal of the infant from parental care, 
or require entry into the social service system. Nurses who advocate for foster care or 
legal ramifications may not be aware of the lack of evidence to support this position and 
that they are in conflict with many nursing organizations (ANA, 2011; AWHONN, 2015).
Legal Perspective
Mandatory reporting of opiate-exposed infants can be used as a proxy for local 
prevalence of maternal opioid use. It may lead to interventions by law enforcement 
or social services. Legislative action toward maternal opiate use is variable between 
states, and is creating disparities in care and intervention (Guttmacher Institute, 2015; 
Young et al., 2009). Some state policies regarding testing and reporting of mothers 
and infants with opiate exposure are more punitive, focusing primarily on the safety 
of the child, whereas others are more preventative and consider the health and well-
being of the pregnant woman and her newborn. Testing and reporting policies can 
vary even within states (National Abandoned Infants Assistance Resource Center, 
2012). Mandatory reporting, therefore, exposes women and infants to very disparate 
outcomes, depending on where they live and how local and state laws are interpreted 
and enforced.
A recent report from the Guttmacher Institute (2015) gives a national perspective of 
state laws. Eighteen states consider substance use in pregnancy child abuse and three 
consider it grounds for civil commitment. Fifteen states require healthcare workers 
to report suspected abuse to the state, and four mandate testing of pregnant women 
(Guttmacher Institute, 2015). A myriad of other laws exist in counties and municipalities, 
and definitions of suspected substance abuse, as well as who is mandated to report 
and when, are not consistent or clear. The potential negative effects that may occur as a 
result of the legal actions taken against prenatal drug abusers are many. These negative 
effects may include, but are not limited to, avoidance of prenatal care, constitutional 
infringements, discrimination, poor prison conditions, and ineffectiveness of punitive 
measures (Coleman & Miller, 2006).
The punitive approach is aimed at cost reduction and social well-being. Nationally, 
costs of all infant drug exposure total between $71 million and $113 million per year, 
but in particular treatment for opiate exposure is extremely costly (National Abandoned 
Infants Assistance Resource Center, 2012). However, legal action has many negative 
unintended consequences. ACOG (2014) states, “policies that deter women from 
seeking prenatal care are contrary to the welfare of the mother and fetus” and that 
“seeking obstetric-gynecologic care should not expose a woman to criminal or civil 
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penalties, such as incarceration, involuntary commitment, loss of custody of her 
children, or loss of housing.” ACOG also points out that it cannot be assumed that a 
pregnant woman who does not receive treatment does not want it, as availability of 
substance abuse treatment for pregnant women is limited (ACOG, 2014; Guttmacher 
Institute, 2015). 
Professional Response
Many health professional organizations instruct their members that their duty is to 
a woman and her baby rather than to law enforcement. This may place healthcare 
workers at odds with state and local ordinances. The American Nurses Association 
(ANA) states that the threat of prosecution undermines nurse efforts to assist women 
seeking care and that nurses should align themselves with social services rather 
than law enforcement to help women and infants (ANA, 2011). The National Perinatal 
Association opposes criminal prosecution of women who abuse substances while 
pregnant, as there is no evidence that this helps the mother or infant (Advocates for 
Pregnant Women, 2011; National Perinatal Association, 2013). The American Society 
of Addiction Medicine (ASAM) supports treatment rather than criminalization as 
incarceration may hurt the health of the mother and fetus, and may not address 
efforts toward long-term recovery (ASAM, 2011). Most recently in January of 2015 the 
Association of Womens’ Health, Obstetric, and Neonatal Nurses (AWHONN) released 
a position statement that, while endorsing a nurses’ responsibility to follow the law, 
opposes incarceration or punitive legal action against women due to substance abuse 
in pregnancy. Additionally they affirmed nurses’ role in supporting mandatory screening 
in all pregnant women for the purpose of providing referrals and treatment to support 
healthy outcomes (AWHONN, 2015).
Working Together
Some have advocated for combined punitive and supportive approaches. The national 
extent of maternal opioid abuse and resulting NAS is not clear, and it is variable around 
the country. Programs aimed at quantifying NAS as a diagnosis, looking at trends in 
geographic areas and in differing populations, are needed. Young et al. (2009) concluded 
we may be missing an opportunity to increase the impact of policy on the issue of 
substance use in pregnancy, and that solutions require public and private entities to 
work together to address how we serve families. Additionally there is opportunity for 
partnerships to identify where differences exist in policy goals versus implementation 
of local laws (Young et al., 2009). 
De-identified mandatory reporting of infants exposed to opiates can provide data to 
drive interventions and has the potential to reduce physical, emotional, and financial 
costs of the NAS epidemic to individuals and society. Programs such as this are 
underway in Tennessee and Florida, the results of which are eagerly awaited (ASTHO, 
2014; CDC, 2015; Bondi, 2014; Tennessee, 2015). Screening and reporting should be 
viewed as part of a larger issue of policy and practice interventions for individuals 
and families. Which mechanism to use for screening, where to collect and house 
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the data, and how the data is used are all questions that need to be addressed. This 
issue requires a clear definition of terms, consistent implementation, and availability 
of treatment interventions, which are currently sparse. According to the Guttmacher 
Institute (2015) only 19 states have drug treatment facilities targeted to pregnant 
women, and only 11 provide these women with priority access. Four states do prohibit 
publicly funded programs from discriminating against pregnant women (Guttmacher 
Institute, 2015).
Family Response
Hogan (2007) provides another distinct point of view in researching how opioid-addicted 
parents view themselves, and how to best intervene. This study looked at various 
factors affecting the parenting ability of opioid addicts. Parents perceived themselves 
to have difficulty being emotionally available and responsive. Additionally, they were 
often separated from their children by incarceration, hospitalization, or drug seeking 
behaviors. The implication of this study is that “support should be targeted at families 
as systems, rather than at drug users as individuals. It should focus on ensuring 
continuity, not only of instrumental caregiving, but also of emotional caregiving to 
children” (Hogan, 2007, p. 17). Clearly all interventions attempted will need a systematic 
population health focus. As stated earlier, nurses need to understand how their actions 
are perceived, and what nursing modalities improve infant outcomes. Nurses’ attitudes 
and actions toward an opioid-exposed mother may interfere with the mother’s self-
worth and ability to care for and bond with her baby (Cleveland & Gill, 2013; Davis & 
Yonkers, 2012; Fraser et al., 2007). Society has much work to do, and nurses who 
encounter these situations daily are well positioned to intervene and create positive 
outcomes for mother-infant dyads experiencing opioid addiction.
Nursing Challenges
Nurses need education regarding substance abuse and different ways to nurse that 
can mitigate challenges and decrease stress. Problems addressed should include 
how nurses are trained regarding NAS, what leads mothers to abuse opiates, and the 
psychosocial effects of the disease on the infant and his caregivers. They also need 
evidence-based strategies that are shown to aid mother and infant through the crucial 
early withdrawal and bonding moments. Velez and Janssen (2008) give a succinct, clear 
message about the care of our vulnerable infants when they describe the interactions 
between the nurse, the mother, and the infant experiencing NAS. They describe how 
dysregulated infants require stable responsive caregivers and how the infants’ behavior 
can alter caregiver behavior. These authors also note that signs displayed by the infant, 
and the modification of the signs with concomitant recovery, depend on the ability of 
the caregiver to interpret these signs and provide appropriate individualized care (Velez 
& Janssen, 2008). Many things affect the mother’s ability to interpret these signs and 
provide this care to her infant; therefore it is incumbent upon the nurse to “assess and 
interpret the infant’s behaviors, determine how the mother understands and responds, 
and tailor interventions” to help the mother have confidence in her ability to care for her 
infant (Velez & Janssen, 2008, p. 119) thereby creating successful mother-infant bonds. 
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Increased perception of support from nursing staff results in decreased likelihood 
of depressive symptoms among opioid-exposed mothers (Davis & Yonkers, 2012). 
Also, there is increasing information that keeping the opioid-exposed mother-infant 
dyad together in the same room and breastfeeding leads to shorter hospital stays 
and increased bonding (Isemann et al., 2011; Saiki et al., 2010). Non-pharmacologic 
intervention and complementary therapies are used in neonates, but they have not 
been widely studied and while they have anecdotal success, they do not have proven 
efficacy (Sublett, 2013). The literature around approaches to pharmacologic and non-
pharmacologic maternal and infant therapies as well as optimal feeding and differences 
in gestational age response is inconsistent (Isemann et al., 2011). The research 
possibilities abound. Validating and implementing potential interventions may go a long 
way toward allowing for increased understanding on the part of nurses and increased 
success of the mother-infant dyad.
Conclusion
While the number of substance-abusing mothers is increasing, so is the understanding 
of the addiction and withdrawal process and how we as professionals might best 
intervene. While current trends may encourage punitive responses to these mothers, 
the evidence is mounting that treatment and support are better options for families 
affected by substance abuse. Professional organizations are unanimous in calling for 
this approach. De-identified mandatory reporting of infants exposed to opiates may 
provide data to drive interventions and therefore has the potential to reduce physical, 
emotional, and financial costs of the NAS epidemic to individuals and society. Screening 
and reporting can be viewed as part of a larger issue of policy and practice interventions 
for individuals, families, and communities. Inter-professional cooperation can aid with 
mutual goal setting for affected mothers and children. Non-punitive policy solutions 
may include drug diversion courts, priority for pregnant women in treatment centers, 
and treatments designed specifically for women. There is a need to educate nurses, 
legislators, and society in general about the addiction disease process, to address 
issues upstream such as reasons that lead to opiate abuse, and to clarify the role of 
legislation and health care providers in the fight against opiate abuse. Educated nurses 
are well positioned to research, advocate, intervene, and create positive outcomes for 
mother-infant dyads experiencing opioid addiction.
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